医学
西洛他唑
依达拉奉
溶栓
阿司匹林
冲程(发动机)
氯吡格雷
神经保护
缺血性中风
内科学
心脏病学
心肌梗塞
缺血
机械工程
工程类
出处
期刊:PubMed
日期:2023-05-01
卷期号:75 (5): 450-455
标识
DOI:10.11477/mf.1416202358
摘要
Ischemic stroke therapy consists of acute phase and preventive treatment strategies. Acute-phase ischemic stroke treatment includes systemic thrombolysis (rt-PA) and mechanical thrombectomy (endovascular therapy). Rt-PA is a very potent thrombolytic agent but its effectiveness is time-dependent. For the prevention of stroke recurrence (secondary stroke prevention) according to the TOAST classification, antiplatelet therapy (aspirin, clopidogrel, and cilostazol) is used for atherothrombotic and lacuna strokes, while anti-coagulant therapy (warfarin and direct oral anticoagulants [DOACs]) are used for cardiogenic cerebral embolism. Additionally, neuroprotective therapy using edaravone, a free radical scavenger, has recently been introduced to minimize brain tissue damage. Recently, neuronal regenerative therapies using stem cells have also been developed.
科研通智能强力驱动
Strongly Powered by AbleSci AI